{"name":"Parion Sciences","slug":"parion-sciences","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMioAJBVV95cUxQblQ2eEttMko4Zk1MM0JDdjNXTURkeXRzLTdfLUVxVy1BQmZqZlNkbXd2cVViSDhiX2dybXE0UldoSHdEbjNTa2pwNF9xeWdFMWlSbzlZUEd6RGJ1SHM2OVVWUEpOeG1nbG9vdFlmalp1YzZNd29uT2R6eTZnZkJSbkJ3bmc0Zi1SdEE5OVA5TGlCc2VmSjM4bHV1enJFUFpFY2RsdmJ0dkJxVFJELXcyMDN1bUNaOU1KSHp2cjJKUEwySWxLYWZSWnM0WWxMZDVzSTdOOU15X3BTSUVNVFpEc2FYU1VfQVQ3RjhUcVpPUkprLU1haGkzN291M3JKMTNKNXloU1lZemtFaTh2R1J0VlNTZ0J0U25EQU91QTVsUGc?oc=5","date":"2026-04-07","type":"trial","source":"Business Upturn","summary":"Severe Asthma Clinical Trial Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | DelveInsight - Business Upturn","headline":"Severe Asthma Clinical Trial Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working in the Therapeutics ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQYUNKQ1E4NUUzNDlCbUdNRDdDbjFlNmw1RWNSRGNUaUJwQzJ3bGlaU3FUQ1ZtS2VVejRSZXZLQWh0amdLam5sX0xrTFFkeXB0cFUzV2lsR0hNZGlMbzdsYURpbnVac2VCWTYxNllVNGVLN2tPdDRwUWtnWHItc2dENnJyNXQ0dDUtaGVUTGNra3BJelpwX2s1LTcwUFM1Y1ZUS3o2MmlMam9jd3Q4clc0d3Z0N29hb2M?oc=5","date":"2025-08-07","type":"regulatory","source":"Journal of Hematology Oncology Pharmacy","summary":"Overview of the Current Development Landscape in Chronic Lymphocytic Leukemia, Part 3 - Journal of Hematology Oncology Pharmacy","headline":"Overview of the Current Development Landscape in Chronic Lymphocytic Leukemia, Part 3","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAJBVV95cUxQbHVQVGNLNTFfUHhJR0dZZUxacTk5eVI1TnpHX0p1cnVCOVJzWGVweWs1MDFaNXk1dUZpTXlHNGV1emppS3RXa3llSno2eTlxTUhITDYyQkV3dEtQallScldQZ25aNm9BN1ctc25zeWpSMG5ITE5MenY1U0E2Z1BqWGdTZVF5SFZCYkZIQzRUQVctZkt4cGtRTGF6U1BCbE1ra0pjZ2tFQ2JtTEtDdkpQVVdQNW8yY2xadmVrazBydmtWdFBHaUFrWXVNWDVlMXV0YkNQbGlJdFVLRWI0Sk1haHhlelB5dkNCRkFWRmdlZE9RNEtzMzBCUXhFank5TG92R3hnT3ZkU0pYeUk3S0V1a3RvVDRJNmR1YnE5X2p0b181V3ljNkFJamdlV3FjX1I5X1JyT0pxU2c?oc=5","date":"2024-11-13","type":"pipeline","source":"GlobeNewswire","summary":"Non-Cystic Fibrosis Bronchiectasis Pipeline Insight: Over - GlobeNewswire","headline":"Non-Cystic Fibrosis Bronchiectasis Pipeline Insight: Over","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxQNTRGNUxfQkVzMlpSTHYxYTNjaDF4YzRiR0VVcVU2VGl6bXFWV0g5bnlndW9NQWtKOXN4QVlRanJfYURXWTJYTmlWM3MxMVF6NDlRdDZ6VnFLNHViclltektYVlhSZVRIbUl5S0M3b01OaVRGd3d6M2pDYS1CS191VzFoeGtGRG1LRzJ1dmFuLWFvSXJVS0ljWGVhUjVIUzVCZlRQSHpyUUt2WFFxX0FVNEdBdzdDbTdyM1BLQWxFUXpOb3dqOUhxVFdPQ0d0dU0?oc=5","date":"2023-09-21","type":"pipeline","source":"Healio","summary":"Idrevloride in hypertonic saline improves lung function in primary ciliary dyskinesia - Healio","headline":"Idrevloride in hypertonic saline improves lung function in primary ciliary dyskinesia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPZFJRYW9oRk5qclpuQUtyWjhPMXRFU3dTX2xWVzRLZkZmQUY0SzNDN1VhM3ZNWDNYc2tsWVZQNkJkeFpnb1k3WXdwM0JrVURUNFBPTkxhVXpTbENiZWctVWFYUC0yWk9EbE0zeXVlRFZFcHJCd3Z5SFM5cG1TYnNFWnJDU2NyakkwQ3lUOTIyTU91WHpZVFlHR3VB?oc=5","date":"2019-06-25","type":"trial","source":"Fierce Biotech","summary":"Verona hires ex-GSK researchers for late-phase push in COPD - Fierce Biotech","headline":"Verona hires ex-GSK researchers for late-phase push in COPD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQLTlySlVsMC1sWWtvV1B2M0wxT25oWWlqcVJJTEpJU3NTTHBfZHpHSmZtbVhTNnlSTkhCNDJHZDk5bkhWd1RibjFFMWw1cWJzaUFJZ0ZsYWJlamJBcjJxSlpneDBMUWhTRkpYTm1lM243RmVreEgydEctbmc3RzRnYzE0X3VPdEVCaXdzVzhFN2c5N0NDVmI1Qm9WR0l2OTBHdlRUcElVRjVjZ1dhcXp6Mk93?oc=5","date":"2017-05-01","type":"deal","source":"BioSpace","summary":"Tiny Parion Sciences Seals Dry Eye Drug Deal Worth $535 Million With Biotech Giant Shire - BioSpace","headline":"Tiny Parion Sciences Seals Dry Eye Drug Deal Worth $535 Million With Biotech Giant Shire","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE9yVE1YM085YjhGa0pFZWRaNEtiX3FiNFhZa3hnVi0wNS1BMzZnXy04WjJNNTVLVFRnQ1VpcnZDYmItYUN1aHlOTm5PeWhNak9KN1gxTGY1TEtkMmJuYjZNRkFoNWxXUWNUcWVNdUlUcnpjMlNNdUJr?oc=5","date":"2017-05-01","type":"pipeline","source":"BioPharma Dive","summary":"Shire commits up to $535M for Parion’s dry eye drug - BioPharma Dive","headline":"Shire commits up to $535M for Parion’s dry eye drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPYjdUVENtQmVIRW9rZG5YMGh1LVR4TEY4QmdOclhyLUIxWW9OTDR1WnMwbE5jMFlId19mQ1A2UUhadXB6NFg1Mk5qbWRkcWR2THFPdzJkNFQ4dEVXUnFqWGQ5b1FkY3paSExvSzdBemhXRUkwUlpRdTNsOU1JSnJ4N0FFM0podDlJVDdfdUJLcWwxcWszM3VB?oc=5","date":"2014-06-13","type":"pipeline","source":"BioPharma Dive","summary":"Parion, Santen bring dry eye drug to Asian markets - BioPharma Dive","headline":"Parion, Santen bring dry eye drug to Asian markets","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}